| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.6M | +545.3% |
| Cost of Revenue | $9.9M | +1250.4% |
| Gross Profit | $1.8M | +64.2% |
| R&D Expense | $14.5M | — |
| SG&A Expense | $66.7M | +6039.3% |
| Operating Income | -$80.2M | — |
| Pre-tax Income | $199.5M | +570.1% |
| Income Tax | $56.4M | +584.7% |
| Net Income | $143.2M | +564.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.6M | +741.4% |
| Accounts Receivable | $355K | -80.3% |
| Current Assets | $524.1M | +464.1% |
| Total Assets | $524.1M | +464.1% |
| Current Liabilities | $3.9M | +28.9% |
| Total Liabilities | $68.6M | +507.3% |
| Stockholders' Equity | $455.6M | +458.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.1M | — |
| Financing Cash Flow | $8.0M | — |